Infective endocarditis

Ten-year review of medical and surgical therapy

Angelo Vlessis, Hagop Hovaguimian, James Jaggers, Aftab Ahmad, Albert Starr

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Background. Infective endocarditis is a complex disease process. Optimal outcome often requires both medical and surgical expertise. The need for and timing of surgical intervention is controversial and continues to evolve in parallel to advancements in diagnosis and treatment. Our experience with the treatment of infective endocarditis is reviewed herein. Methods. A retrospective review was compiled of 140 consecutive patients who fulfilled the modified von Reyn criteria for the diagnosis of endocarditis between January 1982 and April 1992. Results. Patient characteristics, symptoms, and risk factors are described. Follow-up averaged 3.5 ± 0.8 years and totaled 491 patient-years. New York Heart Association functional class at presentation had a significant influence on survival (p 〈 0.0001). Long-term survival was significantly greater (p = 0.036) in patients treated medically/surgically than those treated with medical therapy alone (75% versus 54% at 5 years). Medical treatment of aortic and prosthetic endocarditis was associated with higher mortality (58% and 67%, respectively) when compared with combined medical/surgical treatment (28% and 38%, respectively). Among the survivors, New York Heart Association class at follow-up was better (p 〈 0.0001) in the medical/surgical group (1.05 ± 0.04) versus the medical treatment group (1.70 ± 0.14). Conclusions. Combined medical/surgical treatment for infective endocarditis is associated with improved survival. Patients with aortic or prosthetic endocarditis are identified as subgroups that benefit most from surgical intervention. Valvular dysfunction incited by the infective process is an important factor that should be weighed carefully in the therapeutic decision.

Original languageEnglish (US)
Pages (from-to)1217-1222
Number of pages6
JournalAnnals of Thoracic Surgery
Volume61
Issue number4
DOIs
StatePublished - Apr 1996

Fingerprint

Endocarditis
Therapeutics
Survival
Survivors
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Vlessis, A., Hovaguimian, H., Jaggers, J., Ahmad, A., & Starr, A. (1996). Infective endocarditis: Ten-year review of medical and surgical therapy. Annals of Thoracic Surgery, 61(4), 1217-1222. https://doi.org/10.1016/0003-4975(96)00029-X

Infective endocarditis : Ten-year review of medical and surgical therapy. / Vlessis, Angelo; Hovaguimian, Hagop; Jaggers, James; Ahmad, Aftab; Starr, Albert.

In: Annals of Thoracic Surgery, Vol. 61, No. 4, 04.1996, p. 1217-1222.

Research output: Contribution to journalArticle

Vlessis, A, Hovaguimian, H, Jaggers, J, Ahmad, A & Starr, A 1996, 'Infective endocarditis: Ten-year review of medical and surgical therapy', Annals of Thoracic Surgery, vol. 61, no. 4, pp. 1217-1222. https://doi.org/10.1016/0003-4975(96)00029-X
Vlessis, Angelo ; Hovaguimian, Hagop ; Jaggers, James ; Ahmad, Aftab ; Starr, Albert. / Infective endocarditis : Ten-year review of medical and surgical therapy. In: Annals of Thoracic Surgery. 1996 ; Vol. 61, No. 4. pp. 1217-1222.
@article{155c4462388b49429732d0641def38dc,
title = "Infective endocarditis: Ten-year review of medical and surgical therapy",
abstract = "Background. Infective endocarditis is a complex disease process. Optimal outcome often requires both medical and surgical expertise. The need for and timing of surgical intervention is controversial and continues to evolve in parallel to advancements in diagnosis and treatment. Our experience with the treatment of infective endocarditis is reviewed herein. Methods. A retrospective review was compiled of 140 consecutive patients who fulfilled the modified von Reyn criteria for the diagnosis of endocarditis between January 1982 and April 1992. Results. Patient characteristics, symptoms, and risk factors are described. Follow-up averaged 3.5 ± 0.8 years and totaled 491 patient-years. New York Heart Association functional class at presentation had a significant influence on survival (p 〈 0.0001). Long-term survival was significantly greater (p = 0.036) in patients treated medically/surgically than those treated with medical therapy alone (75{\%} versus 54{\%} at 5 years). Medical treatment of aortic and prosthetic endocarditis was associated with higher mortality (58{\%} and 67{\%}, respectively) when compared with combined medical/surgical treatment (28{\%} and 38{\%}, respectively). Among the survivors, New York Heart Association class at follow-up was better (p 〈 0.0001) in the medical/surgical group (1.05 ± 0.04) versus the medical treatment group (1.70 ± 0.14). Conclusions. Combined medical/surgical treatment for infective endocarditis is associated with improved survival. Patients with aortic or prosthetic endocarditis are identified as subgroups that benefit most from surgical intervention. Valvular dysfunction incited by the infective process is an important factor that should be weighed carefully in the therapeutic decision.",
author = "Angelo Vlessis and Hagop Hovaguimian and James Jaggers and Aftab Ahmad and Albert Starr",
year = "1996",
month = "4",
doi = "10.1016/0003-4975(96)00029-X",
language = "English (US)",
volume = "61",
pages = "1217--1222",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Infective endocarditis

T2 - Ten-year review of medical and surgical therapy

AU - Vlessis, Angelo

AU - Hovaguimian, Hagop

AU - Jaggers, James

AU - Ahmad, Aftab

AU - Starr, Albert

PY - 1996/4

Y1 - 1996/4

N2 - Background. Infective endocarditis is a complex disease process. Optimal outcome often requires both medical and surgical expertise. The need for and timing of surgical intervention is controversial and continues to evolve in parallel to advancements in diagnosis and treatment. Our experience with the treatment of infective endocarditis is reviewed herein. Methods. A retrospective review was compiled of 140 consecutive patients who fulfilled the modified von Reyn criteria for the diagnosis of endocarditis between January 1982 and April 1992. Results. Patient characteristics, symptoms, and risk factors are described. Follow-up averaged 3.5 ± 0.8 years and totaled 491 patient-years. New York Heart Association functional class at presentation had a significant influence on survival (p 〈 0.0001). Long-term survival was significantly greater (p = 0.036) in patients treated medically/surgically than those treated with medical therapy alone (75% versus 54% at 5 years). Medical treatment of aortic and prosthetic endocarditis was associated with higher mortality (58% and 67%, respectively) when compared with combined medical/surgical treatment (28% and 38%, respectively). Among the survivors, New York Heart Association class at follow-up was better (p 〈 0.0001) in the medical/surgical group (1.05 ± 0.04) versus the medical treatment group (1.70 ± 0.14). Conclusions. Combined medical/surgical treatment for infective endocarditis is associated with improved survival. Patients with aortic or prosthetic endocarditis are identified as subgroups that benefit most from surgical intervention. Valvular dysfunction incited by the infective process is an important factor that should be weighed carefully in the therapeutic decision.

AB - Background. Infective endocarditis is a complex disease process. Optimal outcome often requires both medical and surgical expertise. The need for and timing of surgical intervention is controversial and continues to evolve in parallel to advancements in diagnosis and treatment. Our experience with the treatment of infective endocarditis is reviewed herein. Methods. A retrospective review was compiled of 140 consecutive patients who fulfilled the modified von Reyn criteria for the diagnosis of endocarditis between January 1982 and April 1992. Results. Patient characteristics, symptoms, and risk factors are described. Follow-up averaged 3.5 ± 0.8 years and totaled 491 patient-years. New York Heart Association functional class at presentation had a significant influence on survival (p 〈 0.0001). Long-term survival was significantly greater (p = 0.036) in patients treated medically/surgically than those treated with medical therapy alone (75% versus 54% at 5 years). Medical treatment of aortic and prosthetic endocarditis was associated with higher mortality (58% and 67%, respectively) when compared with combined medical/surgical treatment (28% and 38%, respectively). Among the survivors, New York Heart Association class at follow-up was better (p 〈 0.0001) in the medical/surgical group (1.05 ± 0.04) versus the medical treatment group (1.70 ± 0.14). Conclusions. Combined medical/surgical treatment for infective endocarditis is associated with improved survival. Patients with aortic or prosthetic endocarditis are identified as subgroups that benefit most from surgical intervention. Valvular dysfunction incited by the infective process is an important factor that should be weighed carefully in the therapeutic decision.

UR - http://www.scopus.com/inward/record.url?scp=0030115754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030115754&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(96)00029-X

DO - 10.1016/0003-4975(96)00029-X

M3 - Article

VL - 61

SP - 1217

EP - 1222

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 4

ER -